Evidence map›Paper›PMID 24705368›Full record

ArticlePloS one2014

Modeling the natural history and detection of lung cancer based on smoking behavior.

Xing Chen, Millennia Foy, Marek Kimmel, Olga Y Gorlova

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Natural history models for lung Cancer: A scoping review.Lung cancer (Amsterdam, Netherlands) · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xing ChenDepartment of Biomedical Engineering, Key Laboratory of Biomedical Engineering of Ministry of Education of China, Zhejiang University, Hangzhou, Zhejiang, China; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Millennia FoyBrown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, Texas, United States of America.
Marek KimmelDepartments of Statistics and Bioengineering, Rice University, Houston, Texas, United States of America.
Olga Y GorlovaDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America; Department of Community and Family Medicine, Geisel School of Medicine at Dartmouth College, Lebanon, New Hampshire, United States of America.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Relation Between In-utero Vitamin D and Immune Function in Early Childhood P20GM104416 · NIGMS · DARTMOUTH COLLEGE · PI CHRISTENSEN, BROCK CLARKE · 2013 to 2022
$23.7M
ECOGENETIC STUDY OF LUNG CANCER IN MINORITIESR01CA055769 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SPITZ, MARGARET R · 1991 to 2008
$5.3M
Training Program in Biostatistics for Cancer ResearchT32CA096520 · NCI · RICE UNIVERSITY · PI KIMMEL, MAREK, YUAN, YING · 2003 to 2023
$4.5M
A genomewide study of lung cancer in never smokersR01CA149462 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI GORLOVA, OLGA · 2010 to 2014
$4.4M
Modeling Lung Cancer: Risks, Progression, and ScreeningU01CA097431 · NCI · RICE UNIVERSITY · PI KIMMEL, MAREK · 2002 to 2009
$1.8M
NCI NIH HHS CA55769NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA055769NCI NIH HHS R01 CA149462NCI NIH HHS R03CA1338885NCI NIH HHS T32 CA096520NCI NIH HHS U01 CA097431NIGMS NIH HHS P20 GM104416PHS HHS R03128025
6 · The paper itself

Abstract

In this study, we developed a method for modeling the progression and detection of lung cancer based on the smoking behavior at an individual level. The model allows obtaining the characteristics of lung cancer in a population at the time of diagnosis. Lung cancer data from Surveillance, Epidemiology and End Results (SEER) database collected between 2004 and 2008 were used to fit the lung cancer progression and detection model. The fitted model combined with a smoking based carcinogenesis model was used to predict the distribution of age, gender, tumor size, disease stage and smoking status at diagnosis and the results were validated against independent data from the SEER database collected from 1988 to 1999. The model accurately predicted the gender distribution and median age of LC patients of diagnosis, and reasonably predicted the joint tumor size and disease stage distribution.

Indexed as

Models, TheoreticalSmokingAgedAged, 80 and overDisease ProgressionEarly Detection of CancerFemaleHumansLung NeoplasmsMaleMiddle AgedNeoplasm StagingRisk FactorsSEER Program

Identifiers

PMID24705368
PMCPMC3976286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.